HESA-A Attenuates Hepatic Steatosis in NAFLD Rat Model Through the Suppression of SREBP-1c and NF-kβ.

MLA

Efati, M., et al. “HESA-A Attenuates Hepatic Steatosis in NAFLD Rat Model Through the Suppression of SREBP-1c and NF-Kβ.” International Journal of Peptide Research & Therapeutics, vol. 26, no. 3, Sept. 2020, pp. 1283–90. EBSCOhost, https://doi.org/10.1007/s10989-019-09930-3.

APA

Efati, M., Khorrami, M., Jangravi, Z., Mahmoudabadi, A. Z., Raeiszadeh, M., & Sarshoori, J. R. (2020). HESA-A Attenuates Hepatic Steatosis in NAFLD Rat Model Through the Suppression of SREBP-1c and NF-kβ. International Journal of Peptide Research & Therapeutics, 26(3), 1283–1290. https://doi.org/10.1007/s10989-019-09930-3

Chicago

Efati, M., M. Khorrami, Z. Jangravi, A. Z. Mahmoudabadi, M. Raeiszadeh, and J. R. Sarshoori. 2020. “HESA-A Attenuates Hepatic Steatosis in NAFLD Rat Model Through the Suppression of SREBP-1c and NF-Kβ.” International Journal of Peptide Research & Therapeutics 26 (3): 1283–90. doi:10.1007/s10989-019-09930-3.